PrP(C) Aptamer Conjugated–Gold Nanoparticles for Targeted Delivery of Doxorubicin to Colorectal Cancer Cells

Anticancer drugs, such as fluorouracil (5-FU), oxaliplatin, and doxorubicin (Dox) are commonly used to treat colorectal cancer (CRC); however, owing to their low response rate and adverse effects, the development of efficient drug delivery systems (DDSs) is required. The cellular prion protein PrP(C...

Descripción completa

Detalles Bibliográficos
Autores principales: Go, Gyeongyun, Lee, Chang-Seuk, Yoon, Yeo Min, Lim, Ji Ho, Kim, Tae Hyun, Lee, Sang Hun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7922473/
https://www.ncbi.nlm.nih.gov/pubmed/33671292
http://dx.doi.org/10.3390/ijms22041976

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7922473/
https://www.ncbi.nlm.nih.gov/pubmed/33671292
http://dx.doi.org/10.3390/ijms22041976

Ejemplares similares